Updates | Pfizer

April Social Media Round-Up—Trailblazer Cancer Research Grants, World Health Day, and More

Read more about April Social Media Round-Up—Trailblazer Cancer Research Grants, World Health Day, and More

April has come to a close and we are barreling towards the summer. Before you head outside to enjoy spring, take a moment to catch up with Pfizer’s social channels, which have been on fire. Check out updates across our channels.

Making Progress Against Cancer - From Cancer Research to Prevention and Screening

Read more about Making Progress Against Cancer - From Cancer Research to Prevention and Screening

Advances in cancer care often begin with incremental steps in the lab that, over time, have the power to drive transformative breakthroughs. That’s why scientists are working around the clock to develop potential treatments that could help patients live longer, healthier lives. At Pfizer, Sharsti Sandall is one of those scientists.

How Biomarker Testing Helped a Lung Cancer Patient Get the Treatment She Needed

Read more about How Biomarker Testing Helped a Lung Cancer Patient Get the Treatment She Needed

Earlier this month, Science Will Win, Pfizer’s award-winning podcast, wrapped up another successful season. In the second episode of the season, which explored biomarkers and precision medicine’s role in cancer diagnosis and treatment, Dr. Raven sat down with Kelly Huffman, a longtime healthcare professional, former nurse, and Pfizer employee whose life changed a few days before Christmas 2022.

Science Will Win season finale explores AI in cancer care with Pfizer Chief Oncology Officer Jeff Legos

Read more about Science Will Win season finale explores AI in cancer care with Pfizer Chief Oncology Officer Jeff Legos

In February, Pfizer launched the sixth season of Science Will Win, our flagship podcast which recently reached 3 million downloads. The season finale focuses on the future of technology and artificial intelligence (AI) —and what they could mean for cancer research and care.

Ever Wonder How Medicines Get Their Names?

Read more about Ever Wonder How Medicines Get Their Names?

Naming a medicine is more than just a creative exercise. It’s a critical, complicated, and collaborative step in bringing innovative treatments to patients.

March Social Media Round-Up—2025 Annual Review, World’s Most Ethical Companies, and More

Read more about March Social Media Round-Up—2025 Annual Review, World’s Most Ethical Companies, and More

Spring has sprung! At Pfizer, we’re celebrating the changing seasons with exciting updates across our social channels. Catch up on other updates.

Pfizer’s HYMPAVZI Receives Positive CHMP Opinion for Once-Weekly Treatment of Adults and Adolescents with Hemophilia A or B with Inhibitors

Read more about Pfizer’s HYMPAVZI Receives Positive CHMP Opinion for Once-Weekly Treatment of Adults and Adolescents with Hemophilia A or B with Inhibitors

NEW YORK, March 27, 2026 –Pfizer Inc. (NYSE: PFE)announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for HYMPAVZI® (marstacimab) to expand the approved indication to include patients 12 years of age and older weighing at least 35 kg with hemophilia A (congenital factor VIII [FVIII] deficiency) with FVIII inhibitors, or hemophilia B (congenital factor IX [FIX] deficiency) with FIX inhibitors.

Pfizer Among World’s Most Ethical Companies for 5th Straight Year

Read more about Pfizer Among World’s Most Ethical Companies for 5th Straight Year

We are proud to share some news: for the fifth straight year, Pfizer has been recognized as one of the World’s Most Ethical Companies®. This recognition from Ethisphere reflects our continued commitment to integrity, transparency, and doing what’s right for patients, partners, and society.

CEO Albert Bourla Reflects on Pfizer’s Year of Bold Moves and Relentless Innovation in 2025 Annual Review

Read more about CEO Albert Bourla Reflects on Pfizer’s Year of Bold Moves and Relentless Innovation in 2025 Annual Review

2025 was a typically busy year for Pfizer, one of strong performance, disciplined execution and bold moves that position us for future growth and lasting impact for patients around the world as we continue to pursue our mission of making breakthroughs that change people’s lives.

Self -Care for Caregivers

Read more about Self -Care for Caregivers

Caregivers play remarkable and invaluable roles in our communities. They support children, parents, grandparents, spouses, neighbors, and friends.

Subscribe to Updates